University of Ulm
Ulm, 89075, Germany
NCT Number: NCT03481348
During the course of ALS most patients develop swallowing deficits. In this pilot study we investigate if dysphagia in ALS can be improved by Pharyngeal Electrical Stimulation (PES). PES is Communauté Européenne (CE-) certificated and has been approved for treatment of neurological, oropharyngeal dysphagia. During PES, electrical stimuli are applied at the pharynx via a nasogastral tube with the aim of triggering reorganization processes in damaged brain structures. There is evidence of a positive effect of PES in Stroke and Multiple Sclerosis patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Ulm, 89075, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pharyngeal Electrical Stimulation is applied at the pharynx via a nasogastral tube for 10 minutes per day on 3 consecutive days.
Time frame: day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90
Degree of Penetration and Aspiration evaluated by fiberendoscopic evaluation of swallowing (FEES)
Time frame: day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90
swallowing-specific quality of life questionnaire
Time frame: day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90
Clinical scale to evaluate severity of dysphagia
Time frame: day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90
Clinical scale to evaluate the impairment of oral food intake
Time frame: day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90
Clinical scale to evaluate severity of dysphagia
Time frame: day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90
Clinical scale to evaluate the severity of symptoms in ALS
Time frame: day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90
Frequency of Adverse Events
University of Ulm
Other
Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis: A Pilot Study With 20 Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01925196
Amyotrophic Lateral Sclerosis, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05562960
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Taipei, Taiwan
View Trial DetailsNCT04259255
ALS, Amyotrophic Lateral Sclerosis
Phoenix, Arizona, United States
View Trial DetailsNCT05189106
Alzheimer Disease, Amyotrophic Lateral Sclerosis
Boston, Massachusetts, United States
View Trial Details